Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions
Published on: January 19, 2024
Vagus Nerve Stimulation for Epilepsy: An Evidence-Based Approach
1Epilepsy Surgery Program, Clinica de Epilepsia de Sao Paulo and Department of Neurology and Neurosurgery, ABC Faculty of Medicine, Sao Paulo, Brazil.
Abstract:
Medical treatment of seizures yields a satisfactory response in 75-80% of the patients; resective epilepsy surgery is a therapeutic option for those patients who are refractory to drug therapy, but there is still a considerable portion (20-30%) of patients who are ineligible for surgery or failed surgery. Vagus nerve stimulation (VNS) might be an option for these very refractory patients. We carried out an evidence-based search to identify the best evidence presently available related to the use of VNS. We used multiple searchable databases (primary: PubMed-MEDLINE, EMBASE, LILACS, and SciELO; secondary: Cochrane Library) and a standard structured approach know as the PICO scheme: P (patient), I (intervention), C (comparison), and O (outcome). Publications were selected based on study design, PICO components, language, and availability of full text. For study design, we included papers designed as 'randomized controlled trials'; these trials were evaluated according to the Jadad score; the type II error was not used while selecting studies to avoid further limitations. Twenty-eight papers were selected, all from PubMed-MEDLINE. The search results showed that patients older than 12 years with refractory partial seizures (with or without generalization) may benefit from VNS. Children might also benefit, but might need different stimulation parameters. We also noted that higher stimulation settings are associated with increased occurrence of hoarseness, throat pain, cough, and dyspnea. The available randomized controlled trials and cohorts made it clear that VNS is a useful palliative procedure in adult patients with partial epilepsy, and a 50-60% reduction in seizure frequency might be expected in at least 50% of the patients. VNS is a useful palliative procedure in patients with refractory epilepsy. As our practical experience and understanding of the mechanism of action of VNS increase, more homogeneous patient populations that might respond better to VNS are being recognized, such as children with secondary generalized epilepsy and some types of reflex epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Motor Unit Stimulation
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

